Cinnamomum kotoense Kanehira & Sasaki (Lauraceae), is an evergreen small tree, endemic in Lanyu Island of Taiwan. It was cultivated for ornamental purpose in Taiwan Island [1] . In the previous studies, its stem wood was found to contain four butanolides, one secobutanolide, four flavonoids, three flavans, two lignans, eight benzenoids, six steroids, one triterpenoid, one diterpenoid, two furans and nine aliphatic compounds from this species [1] . As part of our continuing investigation of the phytochemical and bioactive compounds of Formosan Lauraceous plants [2, 3] , a new butanolide, kotomolide (1), together with 17 known compounds, obtusilactone A (2) [4] , isoobtusilactone A (3) [4] , secokotomolide (4) [1] , kaempferol (5) [5] , quercetin (6) [6] , (-)-catechin (7) [7] , (-)-epicatechin (8) [8] , (-)-sesamin (9) [9] , isoeugenol (10) [10] , trans-ferulic acid (11) [11] , benzoic acid (12) [12] , p-hydroxybenzoic acid (13) [13] , p-hydroxybenzaldehyde (14) [13] , a mixture of β-sitosterol (15) and stigmasterol (16) [14] , and a mixture of β-sitosterol-D-glucoside (17) and stigmasterol-D-glucoside (18) [15] , were obtained via chromatographic fractionation of the methanolic extract of the stems of this plant. Known compounds 2, 8, 10 and 13 were also isolated for the first time from this species.
Kotomolide (1) was isolated as colorless oil. The molecular formula was determined to be C 22 
EIMS ([M]
+ , m/z 350) and HREIMS. The presence of an α,β-unsaturated-γ-lactone moiety was apparent from UV absorption at 265 nm [14] . The IR spectrum showed an α,β-unsaturated-γ-lactone ring at 1780 and 1680 cm -1 . Chemoprevention by the use of naturally occurring substance has becoming a promising strategy to prevent cancer. We examined the effect of 3, on the proliferation of a human hepatoma Hep G2 cells. Under our experimental conditions, 3 demonstrated to be capable of eliciting a concentration-dependent growth impediment. The demise of these cells induced by 3 was apoptotic in nature as evident by a concentration-dependent increase in sub-G1 fraction as well as the extent of DNA fragmentation. We also found that cells treated with 3 could result in a transient increase of ROS (reactive oxygen species) during the earlier stage of the experiment, followed by the disruption of mitochondrial transmembrane potential. Thus, 3 is a potential chemopreventive agent and further evaluation of its clinical utilization is warranted [16] .
Experimental
General: UV spectra were obtained in CH 3 CN, IR spectra were measured on a Hitachi 260-30 spectrophotometer.
1 H NMR (400 MHz), HETCOR, NOESY, and DEPT spectra were obtained on a Varian (Unity Plus) NMR spectrometer. Lowresolution FABMS and low-resolution EIMS spectra were collected on a Jeol JMS-SX/SX 102A mass spectrometer or Quattro GC/MS spectrometer having a direct inlet system. High-resolution EIMS spectra were measured on a Jeol JMS-HX 110 mass spectrometer. Si gel 60 (Merck, 70~230 mesh, 230~400 mesh) was used for column chromatography. Precoated Si gel plates (Merck, Kieselgel 60 F-254), 0.20 mm and 0.50 mm, were used for analytical TLC and preparative TLC, respectively, visualized with 50% H 2 SO 4 . .5 g). The CHCl 3 -soluble fraction (92.3 g) was chromatographed over silica gel (700 g, 70~230 mesh) using n-hexane/EtOAc/acetone as eluent to produce five fractions. Part of fraction 1 (35.2 g) was subjected to silica gel chromatography by eluting with n-hexane-EtOAc (20:1), then enriched with EtOAc to furnish 10 fractions (1-1~1-10). Fraction 1-2 (3.45 g) eluted with n-hexaneEtOAc (50:1) was further separated using silica gel column chromatography and preparative TLC [n-hexane-EtOAc (50:1)] and gave kotomolide (1) (4 mg). Fraction 1-5 (15.6 g) was further purified by another silica gel column using n-hexane:EtOAc system to obtain 2 (3.2 g) and 3 (4.3 g). Fraction 1-6 (2.5 g) eluted with n-hexane-EtOAc (50:1) was further separated using silica gel column chromatography and preparative TLC [n-hexaneEtOAc (75:1)] and gave 4 (23 mg). Fraction 1-7 (10.2 g) was further purified by another silica gel column using n-hexane: CHCl 3 system to obtain a mixture of 15 and 16 (6.48 g). Part of fraction 2 (23.5 g) was subjected to silica gel chromatography by eluting with n-hexane-EtOAc (1:1), then enriched with EtOAc to furnish 4 fractions (2-1~2-4). Fraction 2-1 (8.4 g) eluted with CHCl 3 -MeOH (100:1) was further separated using silica gel column chromatography and preparative TLC [CHCl 3 -MeOH (100:1)] and gave 12 (11 mg), 13 (25 mg) and 14 (32 mg). Fraction 2-2 (8.8 g) was further purified by another silica gel column using CHCl 3 :MeOH system to obtain 9 (3.1 g). Fraction 2-4 (3.5 g) was further purified by another silica gel column using n-hexane:CHCl 3 system to obtain 10 (51 mg) and 11 (14 mg) . Part of fraction 3 (8.6 g) was subjected to silica gel chromatography by eluting with n-hexaneEtOAc (1:3), then enriched with EtOAc to furnish 5 fractions (3-1~3-5). Fraction 3-3 (3.1 g) was further purified by another silica gel column using CHCl 3 :MeOH system to obtain 7 (14 mg) and 8 (25 mg). Fraction 3-5 (4.2 g) was further purified by another silica gel column using CHCl 3 :MeOH system to obtain 5 (11 mg) and 6 (16 mg). Mixture of 17 and 18 (121 mg) were recrystallized from fraction 5 (7.8 g) to afford crystals. Known compounds were characterized by comparison of their spectroscopic data with literature values [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Supplementary data: Physical and spectral data for obtusilactone A (2), isoobtusilactone A (3) and secokotomolide (4) .
